HM61713, an EGFR-mutant selective inhibitor

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Mutant-specific kinase inhibitors
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Presenter Dong-Wan Kim